3SBio Inc
HKEX:1530

Watchlist Manager
3SBio Inc Logo
3SBio Inc
HKEX:1530
Watchlist
Price: 12.48 HKD -2.95% Market Closed
Market Cap: 29.9B HKD

P/S
Price to Sales

3.1
Current
1.9
Median
6.5
Industry
Higher than median
Lower than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S
3.1
=
Market Cap
29.9B HKD
/
Revenue
9.1B CNY
Market Cap P/S
CN
3SBio Inc
HKEX:1530
29.9B HKD 3.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 35 008 193.5
US
Abbvie Inc
NYSE:ABBV
314.9B USD 5.6
US
Amgen Inc
NASDAQ:AMGN
157.9B USD 4.7
US
Gilead Sciences Inc
NASDAQ:GILD
131.8B USD 4.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
128.7B USD 11.7
US
Epizyme Inc
F:EPE
94.1B EUR 2 012.4
AU
CSL Ltd
ASX:CSL
115.2B AUD 4.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
62.1B USD 4.4
US
Seagen Inc
F:SGT
39.3B EUR 19.4
NL
argenx SE
XBRU:ARGX
31.5B EUR 16.3
Revenue Growth P/S to Growth
CN
3SBio Inc
HKEX:1530
Average P/S: 3 182 752.8
3.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
35 008 193.5
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.6
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.7
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.6
3%
1.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
11.7
10%
1.2
US
E
Epizyme Inc
F:EPE
2 012.4
N/A N/A
AU
CSL Ltd
ASX:CSL
4.8
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.4
7%
0.6
US
S
Seagen Inc
F:SGT
19.4
30%
0.6
NL
argenx SE
XBRU:ARGX
16.3
37%
0.4

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/S
2.8
2-Years Forward
P/S
2.6
3-Years Forward
P/S
N/A